Analyst downgrades: SPRD, AMLN and NWK
Posted Jun 9th 2008 1:01PM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades
.gif)
MOST NOTEWORTHY: Spreadtrum, Amylin Pharma and Network Equipment were today's noteworthy downgrades:
- Roth Capital downgraded Spreadtrum (NASDAQ: SPRD) to Hold from Buy and said recent checks at several Chinese handset companies indicate shipments have been weak since mid April due to sluggish demand and weak macro conditions. The firm does not expect SPRD to meet its Q2 revenue guidance and has lowered estimates and its rating.
- Jefferies downgraded shares of Amylin Pharma (NASDAQ: AMLN) to Hold from Buy as they believe Novo Nordisk's (NYSE: NVO) Liraglutide could prove to be greater-than-expected competition for AMLN's Byetta.
- Network Equipment (NYSE: NWK) was cut at ThinkPanmure to Source of Funds from Buy following the company's reduced guidance based on reduced government spending.
OTHER DOWNGRADES:
- Lehman downgraded European Stocks to Underweight from Overweight.
- Murphy Oil (NYSE: MUR) was cut at JP Morgan to Underweight from Neutral.
- Goldman downgraded Frontier Oil (NYSE: FTO) and Lumber Liquidators (NYSE: LL) to Neutral from Buy.
- Tekelec (NASDAQ: TKLC) was lowered to Hold from Buy at Deutsche Bank.
Tags: amln, downgrade, fto, mur, nwk, sprd, tklc
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
